Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › MDxHealth, LifeLabs Ink Distribution Agreement for Prostate Cancer Assay

MDxHealth, LifeLabs Ink Distribution Agreement for Prostate Cancer Assay

Feb 14, 2019
|
staff reporter

This story has been updated to correct the type of biomarker used in MDxHealth's SelectMDx assay.

NEW YORK (GenomeWeb) – Belgian diagnostic firm MDxHealth announced today that it has signed a distribution agreement with LifeLabs to offer MDxHealth's SelectMDx assay in Canada.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In Molecular Diagnostics

  1. FDA Approves Foundation Medicine CDx, Bayer's Vitrakvi for NTRK Patients

  2. FIND Awarded $60M to Expand COVID-19 Testing

  3. COVID-19 Testing Plays Into Abbott's Long-Term Diagnostic Strategy

    Premium

  4. Helix Coronavirus Test FDA EUA Reissued to Include Specimen Self-Collection

  5. PerkinElmer Multianalyte SARS-CoV-2, Flu Test Gets CE Mark

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.